Anupam Rasayan India Ltd reports FY26 financial results and strategic acquisitions
Anupam Rasayan India · Chemicals & Petrochemicals
Key highlights
- FY26 total revenue rose 65% YoY to ₹2,383.6 crore; EBITDA increased 32% to ₹543 crore
- Q4FY26 revenue was ₹639.2 crore, up 26% YoY; Q4 EBITDA declined 6% YoY to ₹140.7 crore
- Acquired Jayhawk Fine Chemicals (US), delivering proforma revenue of US$95M; agreed to acquire Bliss GVS Pharma
Why it's rated notable: the year-on-year change is 11% (10% to 20% for adverse news)
Figures checked against the filing by a second AI read. About the business, not the share price.
Original filing
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Anupam Rasayan India
- Acquisition / mergerNotableAnupam Rasayan completes acquisition of 48.2% controlling stake in Bliss GVS Pharma
- Board / shareholder meeting outcomeNotableAnupam Rasayan India Ltd approves 23rd AGM, dividend record date, Tanfac share acquisition
- Order winNotableAnupam Rasayan signs six-year supply contract with US specialty metal firm
- Fundraise / allotmentMajor developmentAnupam Rasayan India Ltd credit rating updated by Crisil Ratings Limited
- Fundraise / allotmentNotableAnupam Rasayan India Ltd announces FY26 results, dividend, auditors, and acquisition plans
Other acquisition / merger filings this fortnight
- IndiGrid Infrastructure Trust Q2 FY27 Earnings Conference Call Transcript Released
- Cubical Financial Services Ltd announces promoter reclassification post open offer
- Novus Loyalty Limited approves acquisition of AutoPe Payment Solutions via share swap
- Shish Industries Limited files Composite Scheme of Amalgamation proposal
- Jubilant Ingrevia Limited updates on acquisition of 40% stake in Zettaone Technologies
- NHC Foods approves quarter results, 99.98% Sachmaas Foods investment, two appointments
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.